TY - JOUR
T1 - Etiologies of Rheumatoid Arthritis
T2 - Update on Mucosal, Genetic, and Cellular Pathogenesis
AU - Kronzer, Vanessa L.
AU - Davis, John M.
N1 - Funding Information:
John Davis reports a research grant from Pfizer and has participated on advisory boards for Abbvie and Sanofi-Genzyme, outside the submitted work.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.
PY - 2021/4
Y1 - 2021/4
N2 - Purpose of Review: Over the last few years, the scientific community has made significant progress in understanding the etiology of rheumatoid arthritis (RA). In this review, we summarize those key findings and trends. Recent Findings: New data strongly implicates respiratory exposures, obesity, diet and microbiome, genetics, and their interactions in the etiology of RA. Furthermore, anti-posttranslationally modified protein antibodies (AMPAs) and abnormal glycosylation may be additional biomarkers for RA. Finally, functional genomics techniques implicate loss of certain macrophage populations and proliferation of synovial fibroblasts in RA. Summary: These findings support the notion that RA originates at mucosal sites, augmented by genetic predisposition, and mediated by certain cell types including macrophages and fibroblasts. Weight loss, physical activity, and diet are additional modifiable factors beyond smoking cessation that can reduce risk of RA. Future epidemiologic and translational studies leveraging multi-omics approaches will help map the precise sequence of events in RA pathogenesis.
AB - Purpose of Review: Over the last few years, the scientific community has made significant progress in understanding the etiology of rheumatoid arthritis (RA). In this review, we summarize those key findings and trends. Recent Findings: New data strongly implicates respiratory exposures, obesity, diet and microbiome, genetics, and their interactions in the etiology of RA. Furthermore, anti-posttranslationally modified protein antibodies (AMPAs) and abnormal glycosylation may be additional biomarkers for RA. Finally, functional genomics techniques implicate loss of certain macrophage populations and proliferation of synovial fibroblasts in RA. Summary: These findings support the notion that RA originates at mucosal sites, augmented by genetic predisposition, and mediated by certain cell types including macrophages and fibroblasts. Weight loss, physical activity, and diet are additional modifiable factors beyond smoking cessation that can reduce risk of RA. Future epidemiologic and translational studies leveraging multi-omics approaches will help map the precise sequence of events in RA pathogenesis.
KW - Epidemiology
KW - Etiology
KW - Genetics
KW - Pathogenesis
KW - Review
KW - Rheumatoid arthritis
UR - http://www.scopus.com/inward/record.url?scp=85101874918&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101874918&partnerID=8YFLogxK
U2 - 10.1007/s11926-021-00993-0
DO - 10.1007/s11926-021-00993-0
M3 - Review article
C2 - 33646410
AN - SCOPUS:85101874918
SN - 1523-3774
VL - 23
JO - Current rheumatology reports
JF - Current rheumatology reports
IS - 4
M1 - 21
ER -